The Health Pulse S2E2: The Next Evolution of Decentralized Clinical Trials

On this episode, Greg Horne interviews Craig Lipset, advisor, advocate and educator in the area of decentralized clinical trials and the former head of clinical innovation at Pfizer. During his time at Pfizer, Craig helped design and lead the first fully remote, decentralized trial. Surprisingly, that was more than a decade ago. Craig explains that the methods, investment and regulatory readiness around decentralized clinical trials has long existed in the industry. The pandemic-related disruptions of early 2020 drove meaningful adoption.

Om Podcasten

How can data, AI and advanced analytics accelerate health innovation? Which new technologies hold the most promise? What are the biggest roadblocks to progress? How can we solve endemic problems? Join us for The Health Pulse podcast series as we explore fresh perspectives on digital transformation in health care and life sciences. With a special guest expert on each episode*, we’ll tackle the most pressing issues affecting the delivery of health care and therapies worldwide. All presentations represent the opinions of the presenter and do not represent the position or the opinion of SAS.